Literature DB >> 7564251

DIDMOAD syndrome; further studies and muscle biochemistry.

T G Barrett1, K Poulton, S Bundey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564251     DOI: 10.1007/BF00711771

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  8 in total

1.  Mitochondrial abnormalities in the DIDMOAD syndrome.

Authors:  S Bundey; K Poulton; H Whitwell; E Curtis; I A Brown; A R Fielder
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells.

Authors:  H R Scholte; H F Busch; I E Luyt-Houwen; M H Vaandrager-Verduin; H Przyrembel; W F Arts
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness.

Authors:  M J Jackson; L A Bindoff; K Weber; J N Wilson; P Ince; K G Alberti; D M Turnbull
Journal:  Diabetes Care       Date:  1994-07       Impact factor: 19.112

Review 4.  Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies.

Authors:  X X Zheng; J M Shoffner; A S Voljavec; D C Wallace
Journal:  Biochim Biophys Acta       Date:  1990-08-09

5.  Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome). A review of 88 cases from the literature with personal observations on 3 new patients.

Authors:  C W Cremers; P G Wijdeveld; A J Pinckers
Journal:  Acta Paediatr Scand Suppl       Date:  1977

6.  Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy.

Authors:  R C Duvoisin; W J Nicklas; V Ritchie; J Sage; S Chokroverty
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

7.  Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders.

Authors:  D Aubby; H K Saggu; P Jenner; N P Quinn; A E Harding; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

Review 8.  Mitochondrial mutation commonly associated with Leber's hereditary optic neuropathy observed in a patient with Wolfram syndrome (DIDMOAD).

Authors:  D Pilz; O W Quarrell; E W Jones
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

  8 in total
  3 in total

Review 1.  Wolfram (DIDMOAD) syndrome.

Authors:  T G Barrett; S E Bundey
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

2.  Sarco(endo)plasmic reticulum ATPase is a molecular partner of Wolfram syndrome 1 protein, which negatively regulates its expression.

Authors:  Malgorzata Zatyka; Gabriela Da Silva Xavier; Elisa A Bellomo; Wendy Leadbeater; Dewi Astuti; Joel Smith; Frank Michelangeli; Guy A Rutter; Timothy G Barrett
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

3.  Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome.

Authors:  Maarja Toots; Kadri Seppa; Toomas Jagomäe; Tuuliki Koppel; Maia Pallase; Indrek Heinla; Anton Terasmaa; Mario Plaas; Eero Vasar
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.